Accel Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Accel Wealth Management's LLY Position: Q3 2026 in Review
Accel Wealth Management reduced its Eli Lilly (LLY) stake by 3.1% in Q3 2026, selling an estimated $46K and leaving 1,207 shares worth $1.4M. The position accounts for 0.3% of the portfolio, ranked #74.
Accel Wealth Management first reported a position in LLY in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.5M in Q2 2026. 1,820 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Accel Wealth Management held 1,207 shares of Eli Lilly worth $1.4M as of Q3 2026.
- Accel Wealth Management sold 39 Eli Lilly shares in Q3 2026, an estimated $46K.
- Eli Lilly made up 0.3% of Accel Wealth Management's portfolio in Q3 2026, its #74 holding.
- Accel Wealth Management first reported a position in Eli Lilly in Q4 2020 and has held it in 24 quarters since.
- Accel Wealth Management's Eli Lilly position peaked at $1.5M in Q2 2026.
- 1,820 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Accel Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.